ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 161 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2018. The put-call ratio across all filers is 0.99 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $579,390 | -7.1% | 93,000 | 0.0% | 0.01% | +25.0% |
| Q3 2022 | $624,000 | +5.4% | 93,000 | 0.0% | 0.01% | +33.3% |
| Q2 2022 | $592,000 | +37.0% | 93,000 | 0.0% | 0.01% | +50.0% |
| Q1 2022 | $432,000 | -7.3% | 93,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $466,000 | -95.0% | 93,000 | -74.1% | 0.00% | -90.0% |
| Q4 2020 | $9,328,000 | -30.1% | 358,800 | 0.0% | 0.04% | -52.4% |
| Q3 2020 | $13,336,000 | -2.5% | 358,800 | +34.6% | 0.08% | -27.6% |
| Q2 2020 | $13,680,000 | +158.2% | 266,600 | +123.3% | 0.12% | +314.3% |
| Q3 2018 | $5,298,000 | +13.2% | 119,400 | 0.0% | 0.03% | +27.3% |
| Q2 2018 | $4,680,000 | – | 119,400 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $27,840,842 | 18.82% |
| Ikarian Capital, LLC | 1,891,147 | $11,781,846 | 2.84% |
| Altium Capital Management LP | 620,000 | $3,862,600 | 1.96% |
| Ikarian Capital, LLC | 1,296,900 | $8,079,687 | 1.95% |
| Parkman Healthcare Partners LLC | 822,784 | $5,125,944 | 1.36% |
| Deep Track Capital, LP | 4,000,000 | $24,920,000 | 1.05% |
| Monaco Asset Management SAM | 470,100 | $2,928,723 | 0.88% |
| BRAIDWELL LP | 3,393,405 | $21,140,913 | 0.71% |
| Telemetry Investments, L.L.C. | 71,000 | $442 | 0.70% |
| Rhenman & Partners Asset Management AB | 900,000 | $5,607,000 | 0.58% |